title: Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation.
abstract: The aim of our study is to investigate the effects of chronic sacral neuromodulation on Nitric Oxide (NO) metabolism in the rat bladder. 26 female Sprangue-Dawley rats were considered: group I, normal control rats; group II, a sham treatment, in whom catheters for electrical stimulation were placed in the S1 foramen bilaterally and left in place for 21 days, without performing neuromodulation; group III in whom electrical sacral neuromodulation was performed for 21 days. Finally a cystectomy was performed and the bladder biopsy specimens were sent for immunostaining with n-NOS and i-NOS. Morphological and immunohistochemical analysis was carried out, and evaluated in urothelial cells, endothelial cells and muscle fibers of the muscularis propria. Differences between the 3 groups were analyzed by Student Newman-Keuls test. We could observe that urothelial and endothelial i-NOS (37.00+/-4.69 and 59.00+/-7.42 respectively) and urothelial n-NOS (36.80+/-7.85) expression are significantly increased in neuromodulated rats, compared to groups 1 and 2 (p<0.005). In conclusion, the increase of i-NOS expression on endothelial cells after sacral neuromodulation could be in some way related to angiogenetic responses in the microvascular structures; the increase of n-NOS and i-NOS expression on urothelial cells can suggest that NO is able to influence the plasticity of bladder response, inducing the release of messengers within the urothelium. This study can therefore improve our understanding of the mechanisms of sacral neuromodulation on chronic bladder dysfunction; further studies will need to better demonstrate the role of angiogenesis in the bladder after sacral neuromodulation and to investigate the effects of neuromodulation in rats with chronically induced bladder dysfunction.
authors.affiliation: Institute of Urology, Polytechnic University of the Marche Region, Ancona, Italy. d.minardi@univpm.it
authors.forename: D
authors.initials: D
authors.lastname: Minardi
authors.forename: R
authors.initials: R
authors.lastname: Ghiselli
authors.forename: G
authors.initials: G
authors.lastname: Lucarini
authors.forename: F
authors.initials: F
authors.lastname: Mocchegiani
authors.forename: A
authors.initials: A
authors.lastname: Filosa
authors.forename: A
authors.initials: A
authors.lastname: Zizzi
authors.forename: O
authors.initials: O
authors.lastname: Simonetti
authors.forename: F
authors.initials: F
authors.lastname: Orlando
authors.forename: G
authors.initials: G
authors.lastname: Pelliccioni
authors.forename: G
authors.initials: G
authors.lastname: Parri
authors.forename: V
authors.initials: V
authors.lastname: Saba
authors.forename: L
authors.initials: L
authors.lastname: Lo Muzio
authors.forename: G
authors.initials: G
authors.lastname: Biagini
authors.forename: R
authors.initials: R
authors.lastname: Montironi
authors.forename: G
authors.initials: G
authors.lastname: Muzzonigro
mesh_terms: D000818:Animals; D004599:Electric Stimulation Therapy / Q000379:methods*; D005260:Female; D008160:Lumbosacral Plexus / Q000502:physiology*; D018377:Neurotransmitter Agents / Q000378:metabolism; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000032:analysis / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D001743:Urinary Bladder / Q000201:enzymology*; D001745:Urinary Bladder Diseases / Q000628:therapy
chemical_list: D018377:Neurotransmitter Agents; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase